albicans cells and continue to exist and reinfect the host [144,145,146,147]
Additional Benefits: Both Ozempic and Wegovy are approved to reduce cardiovascular risk in people with heart disease, which is a significant bonus for many patients
Modern treatment options now include oral medications, injectable therapies, biosimilars, insulin analogs, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors
While semaglutide activates only the GLP-1 receptor, tirzepatide is a dual GIP and GLP-1 receptor agonist
is a dual board-certified endocrinologist and obesity medicine specialist who has been in practice for over 20 years
Clarkson, 42, addressed speculation about her weight loss on Monday's episode of "The Kelly Clarkson Show" during an interview with guest Whoopi Goldberg